In this preprint, we described the the NLP classification of clinical trials’ stop reasons that is available in the Open Targets Platform and analysed the availability of genetic support for clinical these studies. We believe this information would be useful for the Open Targets Community on de-risking future studies.
More details in:
-
Why Clinical Trials Stop: The Role of Genetics | medRxiv
-
Twitter thread
-
LinkedIn post
-
Platform documentation
Special thanks to all the authors: Olesya Razuvayeskaya, @irene and @Ian